Search research articles
Contact Us
Filters
Showing results (151-160 of 177) with videos related to
Page
of 18
Sort By:
Cancer
|
June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
J P van Meerbeeck, P Baas, C Debruyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2009
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
K N Syrigos, J Vansteenkiste, P Parikh, et al.
Human Pathology
|
February 24, 1999
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases
M Paulli, J Sträter, U Gianelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
A B Sandler, J Nemunaitis, C Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
M Pecherstorfer, Z Herrmann, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2013
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
S Ramalingam, J Crawford, A Chang, et al.
European Radiology
|
August 9, 2011
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
G Schmid-Bindert, Thomas Henzler, T Q Chu, et al.
International Journal of Cancer
|
July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning, Philipp C Manegold, Young Kwon Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
F Efficace, A Bottomley, E F Smit, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 177) with videos related to
Sort By:
Page
of 18
Cancer
|
June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
J P van Meerbeeck, P Baas, C Debruyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2009
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
K N Syrigos, J Vansteenkiste, P Parikh, et al.
Human Pathology
|
February 24, 1999
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases
M Paulli, J Sträter, U Gianelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
A B Sandler, J Nemunaitis, C Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
M Pecherstorfer, Z Herrmann, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2013
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
S Ramalingam, J Crawford, A Chang, et al.
European Radiology
|
August 9, 2011
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
G Schmid-Bindert, Thomas Henzler, T Q Chu, et al.
International Journal of Cancer
|
July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning, Philipp C Manegold, Young Kwon Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
F Efficace, A Bottomley, E F Smit, et al.
Page
of 18